Literature DB >> 2400031

Environmental tobacco smoke exposure during infancy.

B A Chilmonczyk1, G J Knight, G E Palomaki, A J Pulkkinen, J Williams, J E Haddow.   

Abstract

We collected information about household smoking habits from 518 mothers when they made their first well child visit with a 6 to 8-week old infant. A urine sample was also collected from the infant, the cotinine concentration measured, and the measurement correlated with data provided by the mother. Eight percent of the infant urine cotinine values fell at or above 10 micrograms/L in the 305 households where no smoking was reported. Corresponding rates were 44 percent in the 96 households where a member other than the mother smoked, 91 percent in the 43 households where only the mother smoked, and 96 percent in the 74 households where both the mother and another household member smoked. In households where the mother smoked, infant urine cotinine levels were lower in the summer, and higher when the infant was breast-fed. A screening question about family smoking habits in conjunction with well child care could effectively define a group of infants exposed to environmental tobacco smoke and thus be at greater risk for respiratory diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400031      PMCID: PMC1404829          DOI: 10.2105/ajph.80.10.1205

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Ecology of passive smoking by young infants.

Authors:  R A Greenberg; K E Bauman; L H Glover; V J Strecher; D G Kleinbaum; N J Haley; H C Stedman; M G Fowler; F A Loda
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

2.  Urinary cotinine as marker of breathing other people's tobacco smoke.

Authors:  N J Wald; J Boreham; A Bailey; C Ritchie; J E Haddow; G Knight
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

3.  Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies.

Authors:  G J Knight; P Wylie; M S Holman; J E Haddow
Journal:  Clin Chem       Date:  1985-01       Impact factor: 8.327

4.  Measurement of urinary constituents and output using disposable napkins.

Authors:  S B Roberts; A Lucas
Journal:  Arch Dis Child       Date:  1985-11       Impact factor: 3.791

5.  Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay.

Authors:  G J Knight; G E Palomaki; D H Lea; J E Haddow
Journal:  Clin Chem       Date:  1989-06       Impact factor: 8.327

6.  Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mothers.

Authors:  W Luck; H Nau
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

7.  Measuring the exposure of infants to tobacco smoke. Nicotine and cotinine in urine and saliva.

Authors:  R A Greenberg; N J Haley; R A Etzel; F A Loda
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

8.  Smoking and passive smoking during pregnancy and early infancy: effects on birth weight, lactation period, and cotinine concentrations in mother's milk and infant's urine.

Authors:  D Schwartz-Bickenbach; B Schulte-Hobein; S Abt; C Plum; H Nau
Journal:  Toxicol Lett       Date:  1987-01       Impact factor: 4.372

9.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

10.  Parental smoking and respiratory illness in infancy.

Authors:  D M Fergusson; L J Horwood; F T Shannon
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

View more
  9 in total

1.  Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Jason Wang; Robyn Cohen; Lynne D Richardson; Michael R DeBaun
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

2.  Low cigarette smoking prevalence in peri-urban Peru: results from a population-based study of tobacco use by self-report and urine cotinine.

Authors:  Brooks W Morgan; Kathryn M Leifheit; Karina M Romero; Robert H Gilman; Antonio Bernabe-Ortiz; J Jaime Miranda; Harold I Feldman; John J Lima; William Checkley
Journal:  Tob Induc Dis       Date:  2017-07-21       Impact factor: 2.600

Review 3.  Reducing children's exposure to environmental tobacco smoke in homes: issues and strategies.

Authors:  M J Ashley; R Ferrence
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

4.  To what extent do parents strive to protect their children from environmental tobacco smoke in the Nordic countries? A population-based study.

Authors:  K E Lund; A Skrondal; H Vertio; A R Helgason
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

5.  Environmental tobacco smoke and canine urinary cotinine level.

Authors:  Elizabeth R Bertone-Johnson; Elizabeth Procter-Gray; Audra L Gollenberg; Michele B Ryan; Lisa G Barber
Journal:  Environ Res       Date:  2007-10-22       Impact factor: 6.498

6.  Screening for environmental tobacco smoke exposure among inner-city children with asthma.

Authors:  Jill S Halterman; Belinda Borrelli; Paul Tremblay; Kelly M Conn; Maria Fagnano; Guillermo Montes; Telva Hernandez
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

7.  Exposure of young infants to environmental tobacco smoke: breast-feeding among smoking mothers.

Authors:  M A Mascola; H Van Vunakis; I B Tager; F E Speizer; J P Hanrahan
Journal:  Am J Public Health       Date:  1998-06       Impact factor: 9.308

Review 8.  Environmental tobacco smoke, indoor allergens, and childhood asthma.

Authors:  D R Gold
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

Review 9.  Assessing secondhand smoke using biological markers.

Authors:  Erika Avila-Tang; Wael K Al-Delaimy; David L Ashley; Neal Benowitz; John T Bernert; Sungroul Kim; Jonathan M Samet; Stephen S Hecht
Journal:  Tob Control       Date:  2012-09-02       Impact factor: 7.552

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.